Endoglin (CD105) as a Novel Serum Marker for Hepatocellular Carcinoma (HCC) in Egyptian Patients with Chronic Liver Disease
Ahmed Shoukry Ahmed Emara;
Abstract
The aim of this study was to investigate the potential role of serum endoglin as a diagnostic non invasive marker for HCC and to assess its sensitivity and specificity as a marker of HCC in patients with chronic liver disease.
This study was conducted on
This study was conducted on
Other data
| Title | Endoglin (CD105) as a Novel Serum Marker for Hepatocellular Carcinoma (HCC) in Egyptian Patients with Chronic Liver Disease | Other Titles | اندوجلين (سى دى ١٠٥) كأحد الدلائل الجديدة بالدم لأورام الكبد السرطانية الأولية فى المرضى المصريين المصابين بأمراض الكبد المزمنة | Authors | Ahmed Shoukry Ahmed Emara | Keywords | Endoglin (CD105) as a Novel Serum Marker for Hepatocellular Carcinoma (HCC) in Egyptian Patients with Chronic Liver Disease | Issue Date | 2010 | Description | The aim of this study was to investigate the potential role of serum endoglin as a diagnostic non invasive marker for HCC and to assess its sensitivity and specificity as a marker of HCC in patients with chronic liver disease. This study was conducted on |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 96364p834.pdf | 423.74 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.